Featured Image
Why is it important?
This study shows how polymer- and lipid-based nanocarriers can improve cancer treatment by co-delivering radiosensitizers and photosensitizers for combined radiotherapy and photodynamic therapy (RT–PDT). It discusses how these nanocarriers can encapsulate hydrophilic and hydrophobic agents, potentially improving drug delivery, combining therapeutic effects, and enhancing cancer-cell destruction. The review also examines different polymeric systems, particularly PLGA nanoparticles, the underlying biophysical mechanisms, and the advantages and challenges of co-delivery. Overall, the article highlights the potential of nanotechnology to develop more effective integrated cancer therapies while identifying key barriers to clinical translation.
Read the Original
This page is a summary of: Co-loading Radio-photosensitizer Agents on Polymer and Lipid-based Nanocarriers for Radio-photodynamic Therapy Purposes: Review, Current Pharmaceutical Design, May 2026, Bentham Science Publishers,
DOI: 10.2174/0113816128335001241020162217.
You can read the full text:
Contributors
The following have contributed to this page







